文传商讯
TOXINS 2026: Clinical Updates on Galderma’s Leading Neuromodulator Portfolio Further Reinforce Its
2026-01-15 18:29:21
FDA Accepts New Drug Application for Pimicotinib for the Treatment of Tenosynovial Giant Cell Tumor
2026-01-15 18:29:21
Allianz and Anthropic Forge Global Partnership to Advance Responsible AI in Insurance
2026-01-12 20:32:03



